Simon Fraser University-led clinical research study is evaluating how advanced brain imaging could improve epilepsy surgery in British Columbia. Epilepsy affects more than 50,000 people in B.C., according to the… Read More
As the health care system eagerly awaits the second call for proposals on primary care expansion, the Ministry of Health announced sweeping consultations last week aimed at expanding the scope… Read More
Seltorexant, in combination with an oral antidepressant, demonstrated a numerically greater response rate at week 26 with a more favorable safety and tolerability profile compared to adjunctive quetiapine XR Patients… Read More
Switzerland, Allschwil – Idorsia Ltd. announces that Simcere Pharmaceuticals Group Ltd (2096.HK, “Simcere”) has launched QUVIVIQ® (daridorexant) in China. QUVIVIQ, Idorsia’s dual orexin receptor antagonist, is indicated for the treatment of adult… Read More
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) a leading global medical technology company, announced a pharmacy automation partnership with Henry Ford Health to develop the health system pharmacy of the… Read More
